ADVERTISEMENT
News
Hypokalemia Medication Recalled
03/27/2020
The recall affects 1000-count bottles of potassium chloride extended-release tablets, 750 mg (NDC 64380-861-08), from lots 7238958A (Exp. 7/31/21), 7238257A (Exp. 7/31/21), and 7239404A (Exp. 9/30/21). The tablets were distributed throughout the United States.
Strides Pharma Science Limited initiated the recall February 17, 2020. On March 13, 2020, the FDA designated the recall Class III, suggesting use of the product is not likely to cause harm.
Potassium chloride tablets are available with a prescription to treat low levels of potassium in the blood.
—Jolynn Tumolo